Marcin Kortylewski

14.0k total citations · 6 hit papers
108 papers, 10.5k citations indexed

About

Marcin Kortylewski is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Marcin Kortylewski has authored 108 papers receiving a total of 10.5k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Oncology, 53 papers in Immunology and 39 papers in Molecular Biology. Recurrent topics in Marcin Kortylewski's work include Cytokine Signaling Pathways and Interactions (46 papers), Cancer Immunotherapy and Biomarkers (21 papers) and Immune cells in cancer (19 papers). Marcin Kortylewski is often cited by papers focused on Cytokine Signaling Pathways and Interactions (46 papers), Cancer Immunotherapy and Biomarkers (21 papers) and Immune cells in cancer (19 papers). Marcin Kortylewski collaborates with scholars based in United States, Poland and Germany. Marcin Kortylewski's co-authors include Hua Yu, Drew M. Pardoll, Richard Jove, Maciej Kujawski, H. David Kay, Guilian Niu, Heehyoung Lee, Shumin Zhang, Andreas Herrmann and Tianhong Wang and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Marcin Kortylewski

106 papers receiving 10.4k citations

Hit Papers

Crosstalk between cancer and immune cells: role of STAT3 ... 2003 2026 2010 2018 2006 2003 2005 2009 2005 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment
    2006 1.5k citations Hua Yu, Marcin Kortylewski et al. profile →
  2. Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells
    2003 923 citations Tianhong Wang, Guilian Niu et al. profile →
  3. Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity
    2005 813 citations Marcin Kortylewski, Maciej Kujawski et al. profile →
  4. IL-17 can promote tumor growth through an IL-6–Stat3 signaling pathway
    2009 675 citations Lin Wang, Marcin Kortylewski et al. profile →
  5. Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways
    2005 489 citations Qing Xu, Sungman Park et al. Oncogene profile →
  6. YTHDF2 orchestrates tumor-associated macrophage reprogramming and controls antitumor immunity through CD8+ T cells
    2023 143 citations Marcin Kortylewski, Jianhua Yu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marcin Kortylewski United States 46 5.5k 5.4k 4.3k 1.8k 1.1k 108 10.5k
Eduardo M. Sotomayor United States 51 4.9k 0.9× 6.6k 1.2× 3.9k 0.9× 989 0.5× 1.1k 1.0× 198 11.1k
Xiubao Ren China 48 3.7k 0.7× 3.3k 0.6× 3.9k 0.9× 2.2k 1.2× 429 0.4× 245 8.6k
Luigi Laghi Italy 37 3.7k 0.7× 3.1k 0.6× 2.1k 0.5× 1.1k 0.6× 1.1k 1.0× 103 7.0k
Jacqueline Bromberg United States 44 8.6k 1.6× 3.6k 0.7× 6.6k 1.5× 2.8k 1.6× 2.0k 1.8× 83 13.5k
Richard Moriggl Austria 57 4.4k 0.8× 3.5k 0.6× 3.9k 0.9× 1.4k 0.8× 919 0.8× 176 10.2k
Brian Ruffell United States 33 5.3k 1.0× 7.1k 1.3× 3.4k 0.8× 1.5k 0.8× 286 0.3× 53 10.7k
Veronika Sexl Austria 51 3.6k 0.6× 4.4k 0.8× 3.3k 0.8× 1.1k 0.6× 717 0.6× 183 9.5k
David G. DeNardo United States 49 8.7k 1.6× 9.0k 1.7× 4.5k 1.1× 2.3k 1.2× 404 0.4× 110 15.3k
Ralf C. Bargou Germany 55 6.4k 1.2× 3.2k 0.6× 4.7k 1.1× 918 0.5× 1.9k 1.8× 178 11.7k
Carter Van Waes United States 58 3.8k 0.7× 2.3k 0.4× 4.5k 1.1× 2.7k 1.5× 451 0.4× 155 8.9k

Countries citing papers authored by Marcin Kortylewski

Since Specialization
Citations

This map shows the geographic impact of Marcin Kortylewski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcin Kortylewski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcin Kortylewski more than expected).

Fields of papers citing papers by Marcin Kortylewski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcin Kortylewski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcin Kortylewski. The network helps show where Marcin Kortylewski may publish in the future.

Co-authorship network of co-authors of Marcin Kortylewski

This figure shows the co-authorship network connecting the top 25 collaborators of Marcin Kortylewski. A scholar is included among the top collaborators of Marcin Kortylewski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcin Kortylewski. Marcin Kortylewski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Esposito, Carla Lucia, Ida Autiero, Annamaria Sandomenico, et al.. (2023). Targeted systematic evolution of an RNA platform neutralizing DNMT1 function and controlling DNA methylation. Nature Communications. 14(1). 99–99. 21 indexed citations
2.
Kang, Elaine, Tom Haber, Dayson Moreira, et al.. (2021). Large, Anionic Liposomes Enable Targeted Intraperitoneal Delivery of a TLR 7/8 Agonist To Repolarize Ovarian Tumors’ Microenvironment. Bioconjugate Chemistry. 32(8). 1581–1592. 25 indexed citations
3.
Wu, Xiwei, Yate‐Ching Yuan, Hanjun Qin, et al.. (2021). MicroRNA Regulation of T-Cell Exhaustion in Cutaneous T Cell Lymphoma. Journal of Investigative Dermatology. 142(3). 603–612.e7. 14 indexed citations
4.
Garrido, Greta, Brett Schrand, Agata Levay, et al.. (2020). Vaccination against Nonmutated Neoantigens Induced in Recurrent and Future Tumors. Cancer Immunology Research. 8(7). 856–868. 8 indexed citations
5.
Dorff, Tanya B., Cy A. Stein, Marcin Kortylewski, et al.. (2020). Evaluating Changes in Immune Function and Bone Microenvironment During Radium-223 Treatment of Patients with Castration-Resistant Prostate Cancer. Cancer Biotherapy and Radiopharmaceuticals. 35(7). 485–489. 3 indexed citations
6.
Skrzypek, Klaudia, et al.. (2018). SNAIL is a key regulator of alveolar rhabdomyosarcoma tumor growth and differentiation through repression of MYF5 and MYOD function. Cell Death and Disease. 9(6). 26 indexed citations
7.
Moreira, Dayson, Tomasz Adamus, Xingli Zhao, et al.. (2018). STAT3 Inhibition Combined with CpG Immunostimulation Activates Antitumor Immunity to Eradicate Genetically Distinct Castration-Resistant Prostate Cancers. Clinical Cancer Research. 24(23). 5948–5962. 64 indexed citations
8.
Zhang, Zhuoran, Dayson Moreira, Yu‐Lin Su, et al.. (2018). Inhibition of Survival Signaling in B-Cell Lymphoma Using TLR9-Targeted Delivery of NF-Kb Decoy Oligodeoxynucleotides in Vitro and in Vivo. Experimental Hematology. 64. S113–S113. 1 indexed citations
9.
Brewer, Casey, Bin Zhang, Le Xuan Truong Nguyen, et al.. (2017). MiR-126 Promotes Leukemogenesis in Inv(16) Acute Myeloid Leukemia. Blood. 130. 301–301. 3 indexed citations
10.
Kortylewski, Marcin & Dayson Moreira. (2017). Myeloid cells as a target for oligonucleotide therapeutics: turning obstacles into opportunities. Cancer Immunology Immunotherapy. 66(8). 979–988. 45 indexed citations
11.
Pal, Sumanta K., Xiwei Wu, Hanjun Qin, et al.. (2015). Stool Bacteriomic Profiling in Patients with Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor–Tyrosine Kinase Inhibitors. Clinical Cancer Research. 21(23). 5286–5293. 60 indexed citations
12.
Hossain, Dewan Md Sakib, Sumanta K. Pal, Dayson Moreira, et al.. (2015). TLR9-Targeted STAT3 Silencing Abrogates Immunosuppressive Activity of Myeloid-Derived Suppressor Cells from Prostate Cancer Patients. Clinical Cancer Research. 21(16). 3771–3782. 156 indexed citations
13.
Herrmann, Andreas, Gregory Cherryholmes, Anne Schroeder, et al.. (2014). TLR9 Is Critical for Glioma Stem Cell Maintenance and Targeting. Cancer Research. 74(18). 5218–5228. 60 indexed citations
14.
Herrmann, Andreas, Marcin Kortylewski, Maciej Kujawski, et al.. (2010). Targeting Stat3 in the Myeloid Compartment Drastically Improves the In vivo Antitumor Functions of Adoptively Transferred T Cells. Cancer Research. 70(19). 7455–7464. 110 indexed citations
15.
Kortylewski, Marcin, Maciej Kujawski, Heehyoung Lee, et al.. (2010). Regulation of the IL-23 and IL-12 Balance by Stat3 Signaling in the Tumor Microenvironment. Cancer Cell. 18(5). 536–536. 17 indexed citations
16.
Kortylewski, Marcin, Maciej Kujawski, Andreas Herrmann, et al.. (2009). Toll-like Receptor 9 Activation of Signal Transducer and Activator of Transcription 3 Constrains Its Agonist-Based Immunotherapy. Cancer Research. 69(6). 2497–2505. 99 indexed citations
17.
Niu, Guilian, Jiehui Deng, Yihong Ma, et al.. (2008). Signal Transducer and Activator of Transcription 3 Is Required for Hypoxia-Inducible Factor-1α RNA Expression in Both Tumor Cells and Tumor-Associated Myeloid Cells. Molecular Cancer Research. 6(7). 1099–1105. 151 indexed citations
18.
Harris, Timothy, Joseph F. Grosso, Hung‐Rong Yen, et al.. (2007). Cutting Edge: An In Vivo Requirement for STAT3 Signaling in TH17 Development and TH17-Dependent Autoimmunity. The Journal of Immunology. 179(7). 4313–4317. 484 indexed citations
19.
Burdelya, Lyudmila G., Maciej Kujawski, Guilian Niu, et al.. (2005). Stat3 Activity in Melanoma Cells Affects Migration of Immune Effector Cells and Nitric Oxide-Mediated Antitumor Effects. The Journal of Immunology. 174(7). 3925–3931. 114 indexed citations
20.
Xu, Qing, Sungman Park, Guilian Niu, et al.. (2005). Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways. Oncogene. 24(36). 5552–5560. 489 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eduardo M. Sotomayor Breakdown of academic impact, for papers by Xiubao Ren Breakdown of academic impact, for papers by Luigi Laghi Breakdown of academic impact, for papers by Jacqueline Bromberg Breakdown of academic impact, for papers by Richard Moriggl Breakdown of academic impact, for papers by Brian Ruffell Breakdown of academic impact, for papers by Veronika Sexl Breakdown of academic impact, for papers by David G. DeNardo Breakdown of academic impact, for papers by Ralf C. Bargou Breakdown of academic impact, for papers by Carter Van Waes
Rankless by CCL
2026